NASDAQ · Biotechnology

EWTX (EWTX) Stock

$43.52 -2.03% NASDAQ: EWTX Healthcare

Valuation

MetricValue
Price$43.52
Market Cap$4.68B
P/E Ratio-14.63
P/B Ratio7.41
P/S Ratio0.00
EPS (TTM)$-1.66
52-Week High$48.35
52-Week Low$12.15
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.14%
ROA-25.64%
ROCE-36.65%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio22.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-43.0M$-72.0M$-114.0M$-159.0M$-191.0M
Net Profit$-43.0M$-68.0M$-100.0M$-134.0M$-168.0M
EPS$-0.86$-1.26$-1.57$-1.45$-1.63
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$285.0M$367.0M$340.0M$487.0M$553.0M
Total Liabilities$11.0M$20.0M$21.0M$28.0M$30.0M
Cash$16.0M$22.0M$86.0M$42.0M$61.0M
Borrowings$0$4.0M$5.0M$5.0M$4.0M

Latest News

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business PR Newswire · Jul 13, 2026 Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline PR Newswire · Jul 13, 2026 Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says MT Newswires · Jul 9, 2026 Oppenheimer Initiates Edgewise Therapeutics at Outperform MT Newswires · Jul 9, 2026 Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive Pharmaceutical Technology · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-53.0M$-92.0M$-109.0M$-144.0M
Investing Cash Flow$-243.0M$-76.0M$97.0M$-186.0M$-33.0M
Financing Cash Flow$0$0$1.0M$10.0M$0
Net Cash Flow$-89.0M$6.0M$64.0M$-44.0M$19.0M
Free Cash Flow$-34.0M$-58.0M$-98.0M$-110.0M$-144.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-2.86
EV / EBITDA-16.02
FCF Yield-4.06%
Quick Ratio22.61
Interest Coverage—
Return 1Y187.89%
Return 3Y406.89%
Return 5Y93.74%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLDX $35.80 +0.63% -7.84 $2.38B 0.00%
GLPGGalapagos N.V. $27.98 +1.71% 3.57 $1.84B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%
JANX $16.04 +0.25% -7.78 $978.19M 0.00%
MESOMesoblast Limited $18.24 +8.96% -25.86 $2.36B 0.00%

About EWTX

EWTX stock trades at $43.52 with a market capitalization of $4.68B. The stock is valued at a price-to-earnings (P/E) ratio of -14.63, price-to-book of 7.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $12.15 and $48.35, and currently trades 10.0% below its 52-week high.

On profitability, EWTX generates a return on equity (ROE) of -38.14%, return on capital employed of -36.65%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides